Status:
RECRUITING
RDC Biomarker Study
Lead Sponsor:
Royal Marsden NHS Foundation Trust
Conditions:
Cancer
Eligibility:
All Genders
18+ years
Brief Summary
Rapid Diagnostic Centres Rapid Diagnostic Centres (RDC) were built to diagnose patients who have common symptoms that occur in cancer, but it is unclear if they have cancer or not. These symptoms inc...
Detailed Description
Background The proposed research will focus on Rapid Diagnostic Centres (RDCs) already established across multiple sites in England. Since 2019-2020, RDCs, have begun rolling out nationally across al...
Eligibility Criteria
Inclusion Criteria:
- Patients referred to undergo investigation for suspected cancer within a non-tumour site specific RDC
- Age > 18 years
Exclusion Criteria:
- Previously treated (treatment completed within 5 years preceding recruitment)
- Current confirmed diagnosis of active malignancy
- Unable to or unwilling to give informed consent
Key Trial Info
Start Date :
July 10 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
July 10 2032
Estimated Enrollment :
1000 Patients enrolled
Trial Details
Trial ID
NCT05876676
Start Date
July 10 2023
End Date
July 10 2032
Last Update
April 17 2025
Active Locations (10)
Enter a location and click search to find clinical trials sorted by distance.
1
Aneurin Bevan University Local Health Board
Abergavenny, United Kingdom
2
Glan Clwyd
Bodelwyddan, United Kingdom
3
Harrogate and District NHS Foundation Trust
Harrogate, United Kingdom
4
Kingston and Richmond NHS Foundation Trust
Kingston, United Kingdom